Barclays initiated coverage of Centene with a rating of Overweight and set a new price target of $101.00
Get the next $CNC alert in real time by email
Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $CNC
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/6/2025 | Buy → Hold | Argus | |
| 12/17/2024 | $80.00 → $75.00 | Overweight | Analyst |
| 12/13/2024 | $79.00 → $80.00 | Neutral → Buy | UBS |
| 12/10/2024 | $68.00 → $52.00 | Hold → Underperform | Jefferies |
| 7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies |
| 5/30/2024 | $83.00 | Neutral | Robert W. Baird |
| 3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens |
| 3/6/2024 | $101.00 | Overweight | Barclays |
'Ohana Health Plan Provides Scholarships for Aspiring Nurses at UH West O'ahu
The $25,000 contribution will fund the pre-nursing pathway program for students HONOLULU, March 24, 2025 /PRNewswire/ -- 'Ohana Health Plan, a leading provider of government-sponsored managed care services in Hawaiʻi and a Centene Corporation company (NYSE:CNC), announced today a $25,000 contribution to the University of Hawaii Foundation for the 'Ohana Health Plan Pre-Nursing Scholarship at the University of Hawaiʻi West Oʻahu. The purpose of the ʻOhana Health Plan Pre-Nursing Scholarship - UH West Oʻahu is to assist students enrolled in the pre-nursing program at UH West O'
CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL
ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors
CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED CONTRACT TO SERVE DUALLY ELIGIBLE MEDICARE AND MEDICAID MEMBERS ACROSS THE STATE
ST. LOUIS, March 17, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing Medicare and Medicaid services for dually eligible Illinoisans through a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). The D-SNP program will provide services and support statewide for dually eligible members who qualify for Medicare and Medicaid, as well as dually eligible Managed Long Term Services and Supports (MLTSS) members, unde
Centene downgraded by Argus
Argus downgraded Centene from Buy to Hold
Analyst resumed coverage on Centene with a new price target
Analyst resumed coverage of Centene with a rating of Overweight and set a new price target of $75.00 from $80.00 previously
Centene upgraded by UBS with a new price target
UBS upgraded Centene from Neutral to Buy and set a new price target of $80.00 from $79.00 previously
Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
Director Dallas H James bought $99,904 worth of shares (1,693 units at $59.01) (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
Director Blume Jessica L. bought $14,870 worth of shares (250 units at $59.48) (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
Chief People Officer Mcnally Tanya M covered exercise/tax liability with 1,368 shares and was granted 33,081 shares, increasing direct ownership by 110% to 60,458 units (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
Chief Executive Officer London Sarah covered exercise/tax liability with 20,719 shares and was granted 261,213 shares, increasing direct ownership by 41% to 826,045 units (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
Chief Financial Officer Asher Andrew Lynn covered exercise/tax liability with 8,458 shares and was granted 223,406 shares, increasing direct ownership by 47% to 668,208 units (SEC Form 4)
4 - CENTENE CORP (0001071739) (Issuer)
SEC Form 144 filed by Centene Corporation
144 - CENTENE CORP (0001071739) (Subject)
Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure
8-K - CENTENE CORP (0001071739) (Filer)
Centene Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - CENTENE CORP (0001071739) (Filer)
CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g
Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
Sunshine Health Announces the Appointment of Charlene Zein as President and CEO
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL
ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors
CENTENE CORPORATION REPORTS 2024 RESULTS
-- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December
CENTENE CORPORATION TO HOST 2024 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
SEC Form SC 13G filed by Centene Corporation
SC 13G - CENTENE CORP (0001071739) (Subject)
Amendment: SEC Form SC 13G/A filed by Centene Corporation
SC 13G/A - CENTENE CORP (0001071739) (Subject)
Amendment: SEC Form SC 13G/A filed by Centene Corporation
SC 13G/A - CENTENE CORP (0001071739) (Subject)